Design and synthesis of aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors with enhanced brain permeability
Authors:
- Michael S. MalamasMMMichael S. Malamas
- Albert RobichaudARAlbert Robichaud
- Jim ErdeiJEJim Erdei
- Dominick QuagliatoDQDominick Quagliato
- William SolvibileWSWilliam Solvibile
- Ping ZhouPZPing Zhou
- Koi MorrisKMKoi Morris
- Jim TurnerJTJim Turner
- Erik WagnerEWErik Wagner
- Kristi FanKFKristi Fan
- Andrea OllandAOAndrea Olland
- Steve JacobsenSJSteve Jacobsen
- 1 November 2010
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (22) , 6597-6605
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Recent Developments of Structure Based β-Secretase Inhibitors for Alzheimers DiseaseCurrent Topics in Medicinal Chemistry, 2005
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- Alzheimer's Disease: Genes, Proteins, and TherapyPhysiological Reviews, 2001
- Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organizationNeuroscience, 2001
- Toward a Comprehensive Theory for Alzheimer's Disease. Hypothesis: Alzheimer's Disease Is Caused by the Cerebral Accumulation and Cytotoxicity of Amyloid β‐ProteinAnnals of the New York Academy of Sciences, 2000
- Aβ-Generating EnzymesNeuron, 2000
- Rationalizing a pharmacological intervention on the amyloid precursor protein metabolismTrends in Pharmacological Sciences, 1999
- The Pathogenesis of Senile PlaquesJournal of Neuropathology & Experimental Neurology, 1997
- Alzheimer's Disease--Genotypes, Phenotype, and TreatmentsScience, 1997
- Processing of the β‐Amyloid Precursor Protein and Its Regulation in Alzheimer's DiseaseJournal of Neurochemistry, 1995